Repurposing GLP-1 receptor agonists for parkinson's disease: current evidence and future opportunities
Tirzepatide is administered as a once-weekly subcutaneous injection, with doses gradually titrated from 2.5 mg up to a maximum of 15 mg over several months
At Real Peptides, our vials are clearly labeled with the peptide name and dosage (e.g., 10mg), ensuring you know exactly what you're working with
Preparation of 20% SBE--CD in Saline (4C, storage for one week): 2 g SBE--CD powder is dissolved in 10 mL Saline, completely dissolve until clear
Nomura S, Katoh H, Yanagisawa S, Noguchi T, Okada K, Watanabe M (2023) Administration of the GLP-1 receptor agonist exenatide in rats improves functional recovery after spinal cord injury by reducing endoplasmic reticulum stress
DOI:10.1002/ mds.22401